Lumida
/KRRO
⌘K
Korro Bio Inc

Korro Bio Inc

KRRO
$12.25USD-0.24%-0.03 today

MARKET CAP

176.7M

P/E (TTM)

FWD P/E

DAY RANGE

$12 – $12

52W RANGE

$5
$56

AI Summary

Stalk
Buy NowMedium

KRRO has carved a Stage 1 base after a steep capitulation, enabling mean-reversion entries. The medium-term bias is bullish under mean-reversion eligibility and defined support. Recently, price has held a pullback into the rising 9/21/50-day EMA zone and prior consolidation highs, showing no short-term exhaustion. This presents a favorable entry on a supportive interaction. A breakdown below the EMA confluence and base support would invalidate this bullish posture.

  • High 13F ownership shows institutional confidence in KRRO’s upside.
  • Recent 4.35% price rebound suggests buy interest after oversold drop.
  • Profitability issues and negative earnings yield highlight poor returns.
Full analysis →
Insider Trades8 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 16, 2026SellKRROTodd ChappellChief Operating Officer3,168$10.83$176.7M-78.08%+135.38%$34.3K-15.74%Buy Now
Jun 16, 2026SellKRROOliver DolanSenior Vice President, Finance3,383$10.83$176.7M-78.08%+135.38%$36.6K-15.75%Buy Now
Jun 16, 2026SellKRROLoic A VincentChief Scientific Officer3,418$10.83$176.7M-78.08%+135.38%$37.0K-15.74%Buy Now
Jun 16, 2026SellKRROJeffrey CerioGeneral Counsel6,609$10.83$176.7M-78.08%+135.38%$71.6K-15.77%Buy Now
May 29, 2026SellKRRORam AiyarPresident and CEO15,152$12.98$176.7M-78.08%+135.38%$196.7K-16.84%Buy Now
May 26, 2026BuyKRRORam AiyarPresident and CEO50,000$12.33$176.7M-78.08%+135.38%$616.5K+125.00%Buy Now
Nov 11, 2024SellKRROVineet AgarwalChief Financial Officer1,600$40.84$176.7M-78.08%+135.38%$65.3K+0.00%10b5-1Buy Now
Oct 17, 2024SellKRROVineet AgarwalChief Financial Officer20,432$45.13$176.7M-78.08%+135.38%$922.0K+0.00%10b5-1Buy Now